Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-26-325034
Filing Date
2026-07-30
Accepted
2026-07-30 08:34:55
Documents
66
Period of Report
2026-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q iron-20260630.htm   iXBRL 10-Q 2719520
2 EX-10.1 iron-ex10_1.htm EX-10.1 1418272
3 EX-31.1 iron-ex31_1.htm EX-31.1 16953
4 EX-31.2 iron-ex31_2.htm EX-31.2 16614
5 EX-32.1 iron-ex32_1.htm EX-32.1 10379
  Complete submission text file 0001193125-26-325034.txt   10136180

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT iron-20260630.xsd EX-101.SCH 823219
70 EXTRACTED XBRL INSTANCE DOCUMENT iron-20260630_htm.xml XML 1455257
Mailing Address 321 ARSENAL STREET, SUITE 101 WATERTOWN MA 02472
Business Address 321 ARSENAL STREET, SUITE 101 WATERTOWN MA 02472 (617) 674-9274
Disc Medicine, Inc. (Filer) CIK: 0001816736 (see all company filings)

EIN.: 851612845 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39438 | Film No.: 261220372
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)